Princeton Global Asset Management LLC Aldeyra Therapeutics, Inc. Transaction History

Princeton Global Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.43 - $4.85 $12,150 - $24,250	-5,000 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$7.94 - $11.31 $39,350 - $56,052	4,956 Added 11263.64%	5,000 $44,000
Q3 2021 Nov 03, 2021	SELL	$7.94 - $11.31 $39,350 - $56,052	-4,956 Reduced 99.12%	44 $44,000
Q2 2021 Aug 04, 2021	BUY	$10.44 - $14.85 $36,540 - $51,975	3,500 Added 233.33%	5,000 $57,000
Q4 2020 Feb 09, 2021	BUY	$6.31 - $8.13 $9,465 - $12,195	1,500 New	1,500 $10,000

127

37.6M

757K

539K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $390M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.